中國抗體SM17針對治療哮喘疾病的新藥研究申請獲國家藥監局批准 Aug 14, 2023 21:11 HKT | |
|
SinoMab Announces that IND Application of SM17 for the Treatment of Asthma was Approved by NAMP Aug 14, 2023 21:10 HKT | |
|
四环医药「创新药+医美」双轮驱动战略成效显著 Aug 07, 2023 19:16 HKT | |
|
四環醫藥「創新藥+醫美」雙輪驅動戰略成效顯著 Aug 07, 2023 19:15 HKT | |
|
iTolerance, Inc. and Northway Biotech Announce Partnership Agreement for Manufacturing of Streptavidin-FasL Fusion Protein for Innovative iTOL-100 Immunomodulatory Technology Aug 01, 2023 20:14 HKT | |
|
iTolerance, Inc. and Northway Biotech Announce Partnership Agreement for Manufacturing of Streptavidin-FasL Fusion Protein for Innovative iTOL-100 Immunomodulatory Technology Aug 01, 2023 20:00 HKT | |
|
沛嘉医疗启动TaurusTrio反流瓣膜 内地多中心注册临床研究首日入组成功完成 Aug 01, 2023 16:47 HKT | |
|
沛嘉醫療啟動TaurusTrio反流瓣膜 內地多中心註冊臨床研究首日入組成功完成 Aug 01, 2023 16:46 HKT | |
|
Exploring New Collaborative Opportunities! The Indonesia-China Healthcare and Biotech Investment Forum Successfully Held Jul 31, 2023 19:48 HKT | |
|
Peptomyc Announces the Approval of Its Phase 1b Trial Testing OMO-103 in Combination With Standard of Care in PDAC Patients Jul 28, 2023 06:00 HKT | |
|
亿胜生物宣布贝伐珠单抗眼科适应症I/II期临床研究成功完成 Jul 26, 2023 19:00 HKT | |
|
億勝生物宣布貝伐珠單抗眼科適應症I/II期臨床研究成功完成 Jul 26, 2023 18:59 HKT | |
|
The phase 1/2 clinical trial of Bevacizumab for treatment of Ophthalmic Diseases completed Jul 26, 2023 18:58 HKT | |
|
BioGX Candida Auris PCR Assay Global Adoption Accelerates Jul 25, 2023 00:00 HKT | |
|
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies Jul 24, 2023 20:19 HKT | |
|
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies Jul 24, 2023 19:30 HKT | |
|
沛嘉医疗公布2023年上半年度未经审核营运数据 Jul 21, 2023 20:52 HKT | |
|
沛嘉醫療公佈2023年上半年度未經審核營運數據 Jul 21, 2023 20:51 HKT | |
|
Peijia Medical Announces its Unaudited Operating Statistics for the First Half of 2023 Jul 21, 2023 20:50 HKT | |
|
ADC国际化潜力受捧 科伦博泰或享龙头估值溢价 Jul 20, 2023 20:13 HKT | |
|